Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - STOCK-BASED COMPENSATION
Stock-based Compensation RARE - Ultragenyx Pharmaceutical Inc.
135 M
LAST VALUE
13.50%
2 YEAR CAGR
11.04%
5 YEAR CAGR
70.35%
10 YEAR CAGR